The Foundation intends to provide preventions, treatments & cures for people affected by entire spectrum of retinal degenerative diseases.
The urgent mission of the Foundation Fighting Blindness, Inc. is to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa (RP), macular degeneration, Usher syndrome, and the entire spectrum of retinal degenerative diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 27, 2022 | Grant | $5M | 1 | Diana Davis Spencer Foundation | — | Detail |
Aug 2, 2016 | Grant | $109M | — | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 15, 2022
Nacuity Pharmaceuticals
|
Series B | $16.50M | Health Care | Yes |
Oct 21, 2020
SparingVision
|
Series A | €44.50M | Biotechnology | — |
Apr 1, 2020
Atsena Therapeutics
|
Series A | $8.15M | Biotechnology | Yes |
Jun 1, 2019
Vedere Bio ll
|
Series A | $21M | Biotechnology | — |
Apr 2, 2012
MitoChem Therapeutics
|
Seed | $2M | Biotechnology | Yes |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Diana Davis Spencer Foundation | Yes | Grant |
Foundation Fighting Blindness has had 1 exits. Foundation Fighting Blindness most notable exits include Vedere Bio ll
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Oct 29, 2020 | Vedere Bio ll | M&A | Biotechnology | Detail |